Purpose

This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.

Condition

Eligibility

Eligible Ages
Over 1 Year
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Referred to center for PCD diagnosis considerations - Ability to perform study procedures - Age greater than 2 years of age

Exclusion Criteria

  • Age less than 2 years of age Inability to perform informed consent

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Diagnostic
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Other
Nasal Nitric Oxide testing and collection of clinical data
Participants will have nNO testing is indicated. All participants in this study have some basic clinical data collected at time of enrollment. Participants with a confirmed diagnosis of PCD or in those participants with a working diagnosis of PCD in which ongoing nNO testing is performed have prospective data collection. Some participants have a confirmed diagnosis of PCD by genetics or ciliary biopsy at time of study entry and thus do not need nNO testing, but are followed prospectively with collection of basic clinical data
  • Other: nNO testing
    Collection of already performed clinical data and nNO testing

Recruiting Locations

Vanderbilt Children's hospital
Nashville, Tennessee 37232
Contact:
Michael O'Connor, MD

More Details

Status
Recruiting
Sponsor
Vanderbilt University Medical Center

Study Contact

Michael O'Connor, MD
615.343.7617
michael.g.oconnor@vumc.org

Detailed Description

This study is a prospective data collection of individuals referred to the investigators clinical center for considerations of PCD. Participants sign informed consent to have clinical information entered into a secure electronic database. As part of this study, participants may have nasal nitric oxide (nNO) testing performed. nNO testing is a research procedure, but it is a test with growing utility for making a diagnosis of PCD when performed in the right clinical setting.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.